Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Krawczynski; Krzysztof Z.
Address:
Tucker, GA
No. of patents:
7
Patents:












Patent Number Title Of Patent Date Issued
6455492 Hepatitis E virus vaccine and method September 24, 2002
Antigen and antibody vaccine composition effective in preventing hepatitis E virus (HEV) infection are disclosed. The antigen composition includes peptides corresponding to carboxyl terminal end regions of the second and third open reasing frames of the HEV genome. The composition is eff
6379891 Method of detecting HEV infection April 30, 2002
Viral proteins derived from an enterically transmitted non-A/non-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in individuals infected with the viral hepatitis agent. This protein is useful in a diagnostic
6120988 Method of detecting hev infection September 19, 2000
Viral proteins derived from an enterically transmitted non-A/non-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in individuals infected with the viral hepatitis agent. This protein is useful in a diagnostic
5824649 DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent and characteristic ep October 20, 1998
Viral proteins derived from an enterically transmitted non-A/non-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in individuals infected with the viral hepatitis agent. This protein is useful in a diagnostic
5789559 DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent August 4, 1998
Nucleic acid sequences derived from enterically transmitted nonA/nonB viral hepatitis agent (HEV) are disclosed. DNA sequences encoding specific epitopes within viral protein sequences that are reactive with sera of individuals infected with different strains of HEV are also disclosed.
5770689 Hepatitis E virus ORF Z peptides June 23, 1998
An antigen composition hepatitis E virus (HEV) infection are disclosed. The antigen composition includes peptides corresponding to carboxyl terminal end regions of the second and third open reading frames of the HEV genome.
5741490 Hepatitis E virus vaccine and method April 21, 1998
Antigen and antibody vaccine composition effective in preventing hepatitis E virus (HEV) infection are disclosed. The antigen composition includes a peptide corresponding to a carboxyl terminal end region of the capsid protein encoded by the second open reading frame 2 of the HEV genome.










 
 
  Recently Added Patents
Clusterin antisense therapy for treatment of cancer
Method and apparatus for detecting and tracking vehicles
Method and device for peer arrangement in single substream upload P2P overlay networks
Primed stem cells and uses thereof to treat inflammatory conditions in joints
Multilayer films having reduced curling
Electrical event detection device and method of detecting and classifying electrical power usage
Automatically capturing images that include lightning
  Randomly Featured Patents
Pick-and place package marshalling system
Shoe scraper
Cassette winding apparatus and method for operating
Imaging apparatus that sequentially executes start-up processing based on detected movement
Drive shafts for vehicles and other applications and method for production
Sound channel for a hearing apparatus and corresponding production process
Split rim eyeglass frame mounting
High birefringence liquid-crystalline medium
Polyimide hybrid adhesives
Bonding pad structure and method thereof